ROBIN WINTER-SPERRY (MAPS 2020 Global Annual Meeting Co-Chair; Field Medical FAWG Support)
[vc_row][vc_column][vc_custom_heading text=”Head, Global Field Based Medical Excellence & Insights , Global Medical Operations” el_class=”leader_inner_heading”][vc_custom_heading text=”Sanofi Genzyme” el_class=”leader_inner_heading-2″][vc_column_text el_class=”leader_content”]Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology. She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis’ Medical Science Liaison (MSL) department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division.
She has been involved in over 28 product launches. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.[/vc_column_text][/vc_column][/vc_row]